Quarterly Transactions Made in Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY). The information is specifically focused on institutions that hold shares of ALNYLAM PHARMACEUTICALS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 2,904,219 | 7,496,731 | 10,400,950 | 3,808,340 | 1,325,073 | 5,133,413 | 5,267,537 | |
| Q4 2021 | 5,329,376 | 1,985,831 | 7,315,207 | 4,848,274 | 813,914 | 5,662,188 | 1,653,019 | |
| Q1 2022 | 10,956,195 | 1,451,365 | 12,407,560 | 6,695,252 | 3,216,833 | 9,912,085 | 2,495,475 | |
| Q2 2022 | 8,041,443 | 3,830,876 | 11,872,319 | 8,302,598 | 1,125,265 | 9,427,863 | 2,444,456 | |
| Q3 2022 | 25,057,798 | 7,387,874 | 32,445,672 | 10,900,067 | 16,955 | 10,917,022 | 21,528,650 | |
| Q4 2022 | 8,086,275 | 3,500,829 | 11,587,104 | 20,721,498 | 7,239 | 20,728,737 | -9,141,633 | |
| Q1 2023 | 6,229,494 | 2,446,025 | 8,675,519 | 5,977,424 | 0 | 5,977,424 | 2,698,095 | |
| Q2 2023 | 3,655,924 | 281,012 | 3,936,936 | 5,351,232 | 1,285,178 | 6,636,410 | -2,699,474 | |
| Q3 2023 | 2,859,075 | 2,485,048 | 5,344,123 | 3,969,264 | 1,222,256 | 5,191,520 | 152,603 | |
| Q4 2023 | 3,245,997 | 10,813,879 | 14,059,876 | 6,140,953 | 0 | 6,140,953 | 7,918,923 | |
| Q1 2024 | 6,486,648 | 9,786,399 | 16,273,047 | 9,426,708 | 0 | 9,426,708 | 6,846,339 | |
| Q2 2024 | 10,100,009 | 4,609,814 | 14,709,823 | 5,093,651 | 0 | 5,093,651 | 9,616,172 | |
| Q3 2024 | 11,922,309 | 1,821,650 | 13,743,959 | 6,330,458 | 0 | 6,330,458 | 7,413,501 | |